<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Murata T</submitter><funding>Takeda Science Foundation</funding><funding>Japan Agency for Medical Research and Development</funding><pagination>2265</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9917364</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>24(3)</volume><pubmed_abstract>N6-methyladenosine (m&lt;sup>6&lt;/sup>A) is a post-transcriptional modification of RNA involved in transcript transport, degradation, translation, and splicing. We found that HBV RNA is modified by m&lt;sup>6&lt;/sup>A predominantly in the coding region of &lt;i>HBx&lt;/i>. The mutagenesis of methylation sites reduced the HBV mRNA and HBs protein levels. The suppression of m&lt;sup>6&lt;/sup>A by an inhibitor or knockdown in primary hepatocytes decreased the viral RNA and HBs protein levels in the medium. These results suggest that the m&lt;sup>6&lt;/sup>A modification of HBV RNA is needed for the efficient replication of HBV in hepatocytes.</pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>N6-methyladenosine Modification of Hepatitis B Virus RNA in the Coding Region of &lt;i>HBx&lt;/i>.</pubmed_title><pmcid>PMC9917364</pmcid><funding_grant_id>na</funding_grant_id><funding_grant_id>JP20fk0310104, 22fk0310507</funding_grant_id><pubmed_authors>Murata T</pubmed_authors><pubmed_authors>Iwahori S</pubmed_authors><pubmed_authors>Kimura H</pubmed_authors><pubmed_authors>Nishitsuji H</pubmed_authors><pubmed_authors>Shimotohno K</pubmed_authors><pubmed_authors>Okuno Y</pubmed_authors><pubmed_authors>Yanagi Y</pubmed_authors><pubmed_authors>Watashi K</pubmed_authors><pubmed_authors>Wakita T</pubmed_authors></additional><is_claimable>false</is_claimable><name>N6-methyladenosine Modification of Hepatitis B Virus RNA in the Coding Region of &lt;i>HBx&lt;/i>.</name><description>N6-methyladenosine (m&lt;sup>6&lt;/sup>A) is a post-transcriptional modification of RNA involved in transcript transport, degradation, translation, and splicing. We found that HBV RNA is modified by m&lt;sup>6&lt;/sup>A predominantly in the coding region of &lt;i>HBx&lt;/i>. The mutagenesis of methylation sites reduced the HBV mRNA and HBs protein levels. The suppression of m&lt;sup>6&lt;/sup>A by an inhibitor or knockdown in primary hepatocytes decreased the viral RNA and HBs protein levels in the medium. These results suggest that the m&lt;sup>6&lt;/sup>A modification of HBV RNA is needed for the efficient replication of HBV in hepatocytes.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2025-04-19T17:18:48.613Z</modification><creation>2025-02-19T03:25:54.2Z</creation></dates><accession>S-EPMC9917364</accession><cross_references><pubmed>36768585</pubmed><doi>10.3390/ijms24032265</doi></cross_references></HashMap>